Gonarelin XS [Gonadorelin – 15mg] – 3 Vials – Corey Pauling

Description and Effects

GONARELIN XS [Gonadorelin 5mg X 3 vials] contains Gonadorelin, a synthetic form of gonadotropin-releasing hormone (GnRH). Gonadorelin acts on GnRH receptors in the pituitary gland and stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In men, LH stimulates testosterone production by the testes, while FSH plays an important role in spermatogenesis. Gonadorelin is therefore studied for its role in regulating the hypothalamic-pituitary-gonadal (HPG) axis and supporting endogenous reproductive hormone function.

Product Benefits

• HPG Axis Support: Stimulates the hypothalamic-pituitary-gonadal axis involved in natural reproductive hormone regulation.
• LH and FSH Stimulation: Promotes pituitary release of LH and FSH, two key gonadotropins involved in gonadal function.
• Endogenous Testosterone Support: LH stimulation can promote endogenous testosterone production when the testes and HPG axis remain responsive.
• Reproductive Function Support: LH and FSH contribute to testosterone production and spermatogenesis in men.

Usage Guidelines

• Reference Dosage: A commonly documented gonadorelin dose is 100mcg administered as a single subcutaneous or intravenous injection for stimulation testing.
• Lower-Dose Protocols: Research-oriented protocols may use approximately 50 to 100mcg per administration, with the exact frequency depending on the intended objective.
• Pulsatile Administration: Because physiological GnRH is released in pulses, prolonged gonadorelin protocols may use repeated or pulsatile administration rather than a single daily dose.
• Administration: Subcutaneous administration is commonly used in research and clinical protocols.
• Hormonal Monitoring: LH, FSH, testosterone, estradiol and other relevant markers may be monitored to evaluate the individual response.

Precautions and Wellness

• Possible Side Effects: Headache, dizziness, nausea, flushing, abdominal discomfort, and injection-site reactions may occur.
• Hormonal Response: Gonadorelin stimulates the release of LH and FSH and does not directly replace testosterone.
• Monitoring: Hormonal monitoring may be appropriate during repeated use to assess LH, FSH, testosterone, estradiol, and overall response.
• Medical Supervision: Repeated administration should be performed according to an appropriate medical or research protocol, particularly when used to manipulate reproductive hormone function.
• Storage: Store the lyophilized peptide according to the manufacturer’s instructions. After reconstitution, refrigerate and protect from light.